Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
- 14 September 2007
- Vol. 25 (44), 7656-7663
- https://doi.org/10.1016/j.vaccine.2007.08.042
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Dose‐Related Safety and Immunogenicity of a Trivalent Baculovirus‐Expressed Influenza‐Virus Hemagglutinin Vaccine in Elderly AdultsThe Journal of Infectious Diseases, 2006
- Oculo‐respiratory Syndrome: A New Influenza Vaccine–Associated Adverse Event?Clinical Infectious Diseases, 2003
- Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trialArchives of Internal Medicine, 1996
- Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humansVaccine, 1995
- Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trialJAMA, 1990
- IMMUNITY TO INFLUENZA IN MANAnnual Review of Microbiology, 1983
- Summary of Clinical Trials of Inactivated Influenza Vaccine--1978Clinical Infectious Diseases, 1983
- Summary of Clinical Trials of Influenza Virus Vaccines in AdultsThe Journal of Infectious Diseases, 1977
- A New Subunit Influenza Vaccine: Acceptability Compared with Standard Vaccines and Effect of Dose on AntigenicityThe Journal of Infectious Diseases, 1972
- An Outbreak of Influenza A2 in a Population with a Known Antibody ProfileThe Journal of Infectious Diseases, 1966